Worldwide
In der unten aufgeführten Liste finden Sie alle Mittel, die zur Zeit bei der Faltenunterspritzung Verwendung finden.
Generell unterscheidet man zwei Hauptgruppen:
1. Mittel, die sich langsam (meist hochvernetze Hyaluronsäuren) abbauen.
resorbierbar
2. Mittel, die sich nicht abbauen
nicht resobierbar, permanent
Gängige Mittel zur Faltenunterspritzung
Hersteller
| Produkt | Wirkstoff | Beschreibung | Status |
ABR-Development | Atléan BTCP | BTCP | Tricalcium phosphate suspended in hyaluronic acid | CE mark |
Adoderm | Varioderm Fine Line Varioderm Varioderm Plus Varioderm Subdermal | Non Animal Hyaluronic Acid | Concentration 6 mg/ml Concentration 12 mg/ml Concentration 18 mg/ml Concentration 27 mg/ml
| Marketed in Europe and other countries. |
Alcon Laboratories, Inc. | Silikon 1000 | Silicone | Purified, medical grade polydimethylsiloxane oil-1000 cs. For microdroplet injection. | Silikon 1000 is approved by the FDA for retinal detachments, but not for facial filler indications. Off label use only. |
Allergan | Zyderm 1 | Bovine Collagen | Purified bovine-based collagen 35 mg/ml | Worldwide |
| Zyderm 2 |
| Purified bovine-based collagen 65 mg/ml | Worldwide |
| Zyplast |
| Purified bovine-based collagen 35 mg/ml, crosslinked with glutaraldehyde. | Worldwide |
| CosmoDerm |
| Purified human-based collagen 35 mg/ml | Worldwide |
| Cosmo Plast |
| Purified human-based collagen 35 mg/ml, crosslinked with glutaraldehyde. *All collagen products contain 0,3% Lidocain | Worldwide |
| HydraFill 1-Europe |
| Purified avian large particle size HA 5,5 mg/ml | CE mark |
| HydraFill 2-Europe | Non-animal Hyaluronic Acid | Non-animal, cross linked monophasic hyaluronic acid. | CE mark
|
| HydraFill 3-Europe | Non-animal | Non-animal, cross linked monophasic hyaluronic acid. | CE mark |
| Juvéderm 24 HV
| Hyaluronic Acid | Purified avian large particle size HA 5,5 mg/ml | FDA approved |
| Juvéderm 30 HV
|
| Non-animal, cross linked monophasic hyaluronic acid.
| FDA approved |
| Juvéderm 30 |
| Non-animal, cross linked monophasic hyaluronic acid.
| FDA approved |
Anteis S.A. | Esthélis-Soft 20 mg/ml
| Hyaluronic Acid | Non-animal 5 phase cross-linked hyaluronic acid with CPM (Cohesive Polydensified Matrix) technology. | Approved in Europe, Canada, Israel, South Korea and other markets globally. CE Pending. |
Artes Medical | Artefill | PMMA | 20% polymethylmethacrylate (PMMA) – 32 to 40 microns – 80% purified bovine collagen gel and 0.3% lidocaine. | Worldwide |
BioForm | Radiesse | CaHA | Synthetic calcium hydroxylapatite (CaHA – 55.7%) microspheres, 25 – 45 microns, suspended in an aquaeous polysaccharide gel (1.3% sodium carboxymethylcellulose USP, 6.4% glycerin USP & 36.6% water USP). | Worldwide |
BioForm Medical (Russia) | Argiform | PAAG | Generation polyacrylamide gel comprised of 95% polyacrylamide and 5% water. | N/A |
BioPolymer GmbH & Co. KG | MATRIDEX MATRIDUR MATRIGEL | DEAE Sephadex | MATRIDEX: synthetic hyaluronic acid sodium salt 25 mg, hypromellose 15 mg, positively charged DHEA sephadex particles 25 mg (cross-linked dextran) MATRIDUR: synthetic stabalized hyaluronic acid sodium salt 25 mg and hypromellose 5 mg. MATRIGEL: stabalized HA 12.25 mg.
| CE mark – no FDA approval. |
ColBar LifeScience Ltd. | EVOLENCE 30 | Porcine Collagen | 35 mg of cross – linked porcine (tendons) collagen – glycation with a natural sugar – dispersed in a phosphate buffered saline solution. Glymatrix technology provides a collagen molecule free of telopeptides. | Approved in Europe, Canada, Isreal, South Korea and other markets globally. Not yet approved by the FDA. For investigational use only in U. S. |
Contura International A/S | Aquamid Aquamid Reconstruction
| PAAG | 2.5 % cross-linked hydrophilic polyacrylamide gel (PAAG) and 97.5% water. | Not yet approved by the FDA – trials under way. For investigational use only in U.S. CE marking: CE 0543 – March 2001. Sold in more than 30 countries around the world. |
Dermabiol Institute of Kuhra Vital GmbH | Rhegecoll | PMMA | Rhegecoll: 40% bovine collagen from U.S. calves, 15% A.D.N., 5% embryoblastos (stem cell) 10% polymethacrylate, 15% copolymer 4-G, 15% stabilizer / emulsifier. | Not approved in U.S., worldwide registrations pending. |
Dermatech (Paris) | DermaLive | HEMA / EMA | 60% stabilized hyaluronic acid plus 40% acrylic hydrogel (hydroxyethylmetacrylate – HEMA and ethylmetacrylate (EMA) co-polymer particles by volume. DermaLive – 200mg 45-65 micro beads, 14.4 mg HA. Dermadeep – 200 mg 80 110 micro beads, 14.4 mg HA. | DermLive – Approved in Europe 1998, Canada 2003. Dermadeep – Approved in Europe 1998, Canada 2003. |
Fascia Biosystems | Fascian | Fascia | Human allograft material – fascia, collected from human cadaver donors. Reconstituted with sterile normal saline, 0.5% lidocaine. | Fascian is a tissue product as classified by FDA, there are no off-label uses – hence a physician can use as desired. |
FibroGen, Inc. | FG-5017 (rhCIII) – synthetic human collagen (type III). | Human Collagen | Fg-5017 dermal filler is comprised of a cross-linked formulation of recombinant human collagen type III in saline with lidocaine. Formed collagens based on human DNA sequences in yeast cultures. | Pending approval. Completed human safety clinical trial of recombinant human collagen type III. The pivotal efficacy and safety study required |
FuHua High Molecular Matter Company, Ltd. | Amazingel | PAAG | Hydrohilic Polyacrylamide Gel. | Approved in Asia – China in 2000. |
FzioMed, Inc. | Laresse Dermal Filler | Carboxymethylce-llulose, Polyethylene Oxide | Non-permanent, long lasting, ultra smooth dermal filler, containing no bacterial or animal by-products, no cross-linking chemicals and no gel particles. | CE mark approved. |
Isolagen, Inc. | Isolagen | Autologous fibroblast cells | Isolagen – autologous cellular system – cultured human fibroblasts. | Available only in UK. Filed IND with FDA – approved. |
Ladoratories ORGe´V | MacDermol S MacDermol R
| Avian Hyaluronic Acid / Chitosan | MacDermol S – Avian non cross-linked hyaluronic acid (2.1%) sodium chloride. MacDermol R – Avian cross-linked hyaluronic acid (3.4%) chitosan chondroitin sulphate sodium chloride.
| CE mark – no FDA approval. |
LVA Pharmaceutical | Hyaluderm | Hyaluronic Acid | Hyaluderm – non cross-linked sodium hyluronate, 2.0% to 2.5%. | CE mark – no FDA approval. |
Medicis | Restylane Restylane Touch Restylane Perlane Restylane Sub-Q | NASHA | NSAHA gel – animal hyaluronic acid, stabilized with BDDE. The differentiation is in the size of the NASHA particles, to assure a tissue-tailored rang of products. Restylane Touch – 500,000 particles per ml. Restylane – 100,000 particles per ml. Restylane Perlane – 10,000 particles per ml. Restylane Sub-Q – 1,000 particles per ml. | Restylane is approved in the U.S. and Canada. Restylane Perlane and Restylane Fine Lines are approved in Canada / pending FDA approval. Sub-Q is in the approval process. |
Mentor Corporation in conjunction with Genzyme Corporation | Puragen Puragen Plus Prevelle Prevelle plus | Hyaluronic Acid | Puragen/Puragen Plus: Non-animal derived double cross-linked (DXL technology) hyaluronic acid – 20 mg/ml. Prevelle/Prevelle Plus: Non animal derived cross-linked hyaluronic acid, 5.5 mg/ml. Mentor`s Plus products contain lidocaine integrated directly into the formulation. | Puragen/Puragen Plus: Europe clearance – CE mark. FDA clearance pending. Prevelle/Prevelle Plus: Europe clearance – CE mark. FDA clearance pending. |
Merz Pharma GmbH & Co. KgaA | Belotero Soft – 22.5 mg/ml Belotero Basic – 20 mg/ml | Hyaluronic Acid | Non-animal double phase cross-linked hyaluronic acid – via biofermentation – with CPM (Cohesive Polydensified Matrix) technology. | CE mark – October 2004 – Merz received the marketing rights for Germany, Austria, Switzerland, Russia and Italy from Anteis SA. U.S. approval pending. |
Polymekon | BIO-ALCAMID – Face BIO-ALCAMID – Lips BIO-ALCAMID – Body | Poly – Acrylamid
| BIO-ALCAMID – 96% water and 4% synthetic reticulate polymer (poly-Alkyl-mide). Lips is soft and compact. Face has the same composition (it is not a dilution), Body has the same consistency as the Face from, but contains more material. | BIO-ALCAMID – CE mark in 2001 – no FDA approval.
|
| Bioinblue – Lips Bioinblue – DeepBlue | PVA | Bioinblue – PVA (polyvinyl alcohol 8%) and water (92%). | Bioinblue – CE mark in 2003 – no FDA approval. |
ProCytech SA | Outline Fine Outline Original Outline Ultra | Poly- Acrylamide-co-DADMA | Outline is absorbable poly (acrylamide-co-DADMA) gel. | Approved in Europe |
| Evolution | Evolution is a mixture of microscopic soft spheres of polyvinyl in a viscoelastic gel of poly (acryl-lamide-co-DADMA) gel |
|
|
Prollenium Medical Technologies | Revanesse Revanesse Ultra ReDexis
| Hyaluronic Acid | Revanesse-cross-linked HA 25 mg, hypromellose 12,5 mg Revanesse Ultra-high viscosity, cross-linked,reticulated hyaluronic acid 25 mg, hypromellose 15 mg. ReDexis-cross-linked reticulated hyaluronic acid 25 mg, hyprmellose 15 mg, dextronomer DEAE 25 mg. | Approved in Canada. U.S. Approval pending. |
Q-Med AB | Restylane Restylane Touch Restylane Perlane Restylane Sub-Q Restylane Lipp Restylane Vital
| NASHA | NASHA gel- a non animal hyaluronic acid, stabilized with BDDE. The differentiation is in the size of the NASHA particles, to assure a tissue-tailored range of products. Restylane Touch-500,000 particles per ml. Restylae-100,000 particles per ml. Restylane Perlane-10,000 particles per ml. Restylane Sub-Q-1,000 particles per ml. | Restylane is approved worldwidecwith the exception of Japan. Restylane Perlane, Restylane Sub-Q and Restylane Touch are approved worldwide with the exception of Japan and U.S U.S. approval in progress. Restylane Lipp approved in Europe. |
Rofil/Philoderm | REVIDERM Rofilan Beautical 2 Beautical 5 | Dextran-Sephadex Hyaluronic Acid Poly Acrylamide | REVIDERM-25 mg/ml sephadex (Dextran) 40-60 microns, 20 mg/ml cross linked synthetic hyaluronic acid. Rofilan-20 mg/ml cross linked synthetic hyaluronic acid. Beautical 2-Polyacrylamid gel. Beautical 5-Polyacrylamid gel. | Approval in Europe, Canada and most other countries. Not approved in the U.S. |
Sanofi-Aventis | Sculptra-U.S., also known as New Fill or New-Filla | PLLA | Poly-L-Lactic acid (PLLA) hydrogel belonging to the family of aliphatic polyesters. Synthesized from corn. | FDA has approved Sculptra as the only product for the restoration and/or correction of the signs of facial fat loss (lipoatrophy).Approved in Europe in 2000 as NewFill-2004 as Sculptra for facial aesthetic use. |
Teoxane SA | Teosyal Global actionm Teosyal Deep Lines Teosyal Ultra Deep Teosyal Kiss | Hyaluronic Acid | Monophasic cross-linked non-animal hyaluronic acid gel macro-molecules-25 mg/ml. | Europe CE mark.U.S. approval in progress. |
Uroplasty | Bioplastique | Silicone | Solid silicone microspheres (100 to 400 and 600µ) suspended in a polyvinylpyrrolidone vector. | CE mark |